JoelStevenLippmanMD

Physician

Dr. Lippman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

69 citations
Triphasic norgestimate-ethinyl estradiol for treating dysfunctional uterine bleeding.
Ann J. Davis, Amy Godwin, Joel Lippman, William Olson, Michael E. Kafrissen
Obstetrics and Gynecology. 2000-12-01
94 citations
Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials.
James A. Simon, David Portman, Andrew M. Kaunitz, Hana Mekonnen, Kazem Kazempour
Menopause. 2013-10-01
26 citations
Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause.
JoAnn V. Pinkerton, Hadine Joffe, Kazem Kazempour, Hana Mekonnen, Sailaja Bhaskar
Menopause. 2015-01-01

Noven Pharmaceuticals, Inc. Press Release : FDA Approves Once-Daily XELSTRYM™ (Dextroamphetamine) Transdermal System, CII, for the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Adults and Pediatric Patients 6 Years and OlderMarch 23rd, 2022
Noven to Present Pivotal Study Results for Investigational Dextroamphetamine Transdermal System for Pediatric ADHD PatientsApril 27th, 2021
F.D.A. Approves a Drug for Hot FlashesJune 29th, 2013
Join now to see all